Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 23:13:1019638.
doi: 10.3389/fimmu.2022.1019638. eCollection 2022.

Nomogram established on account of Lasso-Cox regression for predicting recurrence in patients with early-stage hepatocellular carcinoma

Affiliations

Nomogram established on account of Lasso-Cox regression for predicting recurrence in patients with early-stage hepatocellular carcinoma

Qi Wang et al. Front Immunol. .

Abstract

Purpose: To investigate the risk factors for recurrence in patients with early-stage hepatocellular carcinoma (HCC) after minimally invasive treatment with curative intent, then to construct a prediction model based on Lasso-Cox regression and visualize the model built.

Methods: Clinical data were collected from 547 patients that received minimally invasive treatment in our hospital from January 1, 2012, to December 31, 2016. Lasso regression was used to screen risk factors for recurrence. Then we established Cox proportional hazard regression model and random survival forest model including several parameters screened by Lasso regression. An optimal model was selected by comparing the values of C-index, then the model was visualized and the nomogram was finally plotted.

Results: The variables screened by Lasso regression including age, gender, cirrhosis, tumor number, tumor size, platelet-albumin-bilirubin index (PALBI), and viral load were incorporated in the Cox model and random survival forest model (P<0.05). The C-index of these two models in the training sets was 0.729 and 0.708, and was 0.726 and 0.700 in the validation sets, respectively. So we finally chose Lasso-Cox regression model, and the calibration curve in the validation set performed well, indicating that the model built has a better predictive ability. And then a nomogram was plotted based on the model chosen to visualize the results.

Conclusions: The present study established a nomogram for predicting recurrence in patients with early-stage HCC based on the Lasso-Cox regression model. This nomogram was of some guiding significance for screening populations at high risk of recurrence after treatment, by which doctors can formulate individualized follow-up strategies or treatment protocols according to the predicted risk of relapse for patients to improve the long-term prognosis.

Keywords: Lasso-Cox regression; hepatocellular carcinoma; nomogram; prediction; recurrence.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Screening of variables based on Lasso regression. (A) The variation characteristics of the coefficient of variables; (B) the selection process of the optimum value of the parameter λ in the Lasso regression model by cross-validation method.
Figure 2
Figure 2
The recurrence risk analysis of HCC based on random survival forest. (A) Error rate of random survival forest; (B) out-of-bag variable importance ranking. HCC: hepatocellular carcinoma.
Figure 3
Figure 3
Calibration plots of predicted 1-, 3-, and 5-year RFS based on Cox regression modeling in the training set and validation set. (A–C) training set; (D–F) validation set. RFS, recurrence-free survival.
Figure 4
Figure 4
The Kaplan-Meier curves by tertiles of predicted 1-, 3, and 5-year RFS according to the two modeling approaches in validation set. (A–C) Cox regression modeling; (D–F) random survival forest. RFS, recurrence-free survival.
Figure 5
Figure 5
Nomogram used to predict time-related recurrence in patients with early-stage HCC. HCC, hepatocellular carcinoma.

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin (2021) 71(3):209–49. doi: 10.3322/caac.21660 - DOI - PubMed
    1. Villanueva A. Hepatocellular carcinoma. N Engl J Med (2019) 380:1450–62. doi: 10.1056/NEJMra1713263 - DOI - PubMed
    1. Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. . Hepatocellular carcinoma. Nat Rev (2021) 7:6. doi: 10.1038/s41572-020-00240-3 - DOI - PubMed
    1. Wong JS, Wong GL, Tsoi KK, Ye R, Zhu Y, Zhou L, et al. . Meta-analysis: the efficacy of antiviral therapy in prevention of recurrence after curative treatment of chronic hepatitis b-related hepatocellular carcinoma. Aliment Pharmacol Ther (2011) 33:1104–12. doi: 10.1111/j.1365-2036.2011.04634.x - DOI - PubMed
    1. Wen L, Weng S, Yan C, Ye R, Zhu Y, Zhou L, et al. . A radiomics nomogram for preoperative prediction of early recurrence of small hepatocellular carcinoma after surgical resection or radiofrequency ablation. Front Oncol (2021) 11:657039. doi: 10.3389/fonc.2021.657039 - DOI - PMC - PubMed